Literature DB >> 10645842

Electrocardiographic manifestations: patterns that confound the EKG diagnosis of acute myocardial infarction-left bundle branch block, ventricular paced rhythm, and left ventricular hypertrophy.

W J Brady1, T C Chan, M Pollack.   

Abstract

The 12-lead electrocardiogram (EKG), a powerful tool used in evaluating the chest pain patient, has its shortcomings. One such failing is encountered in a patient with one of the following electrocardiographic patterns: left bundle branch block (LBBB), ventricular paced rhythm (VPR), and left ventricular hypertrophy (LVH). These patterns reduce the ability of the EKG to detect acute coronary ischemic change and acute myocardial infarction (AMI). Several strategies are available to assist in the correct interpretation of these complicated electrocardiographic patterns, including a knowledge of the ST segment-T wave changes associated with these confounding patterns, performance of serial EKGs, and comparison with previous EKGs if available. This article suggests guidelines and interpretive tools for diagnosing AMI on EKG in patients with these confounding patterns.

Entities:  

Mesh:

Year:  2000        PMID: 10645842     DOI: 10.1016/s0736-4679(99)00178-x

Source DB:  PubMed          Journal:  J Emerg Med        ISSN: 0736-4679            Impact factor:   1.484


  3 in total

1.  The electrocardiographic differential diagnosis of ST segment depression.

Authors:  T Pollehn; W J Brady; A D Perron; F Morris
Journal:  Emerg Med J       Date:  2002-03       Impact factor: 2.740

2.  Observer variability in ECG interpretation for thrombolysis eligibility: experience and context matter.

Authors:  David Massel
Journal:  J Thromb Thrombolysis       Date:  2003-06       Impact factor: 2.300

3.  Vectorcardiography risk stratifies emergency department chest pain patients with left ventricular hypertrophy on the initial 12-lead ECG.

Authors:  Francis M Fesmire; Sven V Eriksson
Journal:  Ann Noninvasive Electrocardiol       Date:  2004-04       Impact factor: 1.468

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.